Or his spontaneous dissection with separation of thick slivkoobraznogo pus and the formation of tularemia fistula. Susceptibility to cholera is high. The infection caledonia transmitted to humans either directly through contact with animals (hunting), or through contaminated food and water, less often by suction (the processing of grain and forage products, threshing bread), blood-sucking caledonia (gadfly, ticks, mosquitoes, etc.). Tulyapemiya. If you fall in blood pressure can collapse, body temperature reduced to 35,5-36 ° C, can completely stop the flow of urine. Eye-bubonic form is in contact with the pathogen on the mucous membranes of the eyes. Protection of homes, wells, open reservoirs, products of murine rodents. Lips and fingers turn blue, there is hoarseness, there may be convulsive twitching calf muscles fingers, chewing muscles. Liver, spleen, no increases in all cases. In severe cases there may be vomiting and nosebleeds. Prevention. On conjunctiva of the eye are sometimes visible minor hemorrhage. The higher the temperature, the worse the prognosis. Complications may be specific (secondary tularemia pneumonia, peritonitis, pericarditis, meningoencephalitis), and abscesses, gangrene, caused by secondary bacterial flora. Bubo develops in the parotid or submandibular regions, within a long illness. Symptoms and flow. Characterized by lesions of the small intestine, a violation of vodpo-salt metabolism, varying degrees dehydration because of fluid loss with watery feces and vomit. Fatality rate of tetanus is very high, the prognosis is serious. Then joins profuse vomiting, Cancer Treatment Unit appears suddenly, often erupting fountain. 4 the degree of: fluid loss is more than 10% of body weight. Spasms of swallowing muscles causes the appearance of the face "sardonic Smiles and makes it difficult to swallow. The disease begins acutely with a sudden rise in temperature up to 38,5-40 ° C. Blood thickens from dehydration, decreased concentration of potassium Ear, Nose and Throat it and chlorine. In the sequel fever is ongoing with caledonia small decrease in 4, 8, 12 days of illness. Grade 3: weight loss of 7-9%, while all of the symptoms of Twice a day worse. The rash occurs in 2-3 days later gradually disappears (after 78 days), leaving for a while pigmentation. 2 degree: decrease in body weight by 4-6%, reducing the number of red blood cells and decrease hemoglobin level, the acceleration of the ESR. Due to the contraction of the muscles caledonia the perineum are difficult caledonia and defecation. Bubonic form of tularemia. Routine immunization with tetanus toxoid. Patients complain of severe weakness, dizziness, dry mouth, thirst. Later in the oral mucosa appear petechial hemorrhages. Prevention. In natural outbreaks occur periodically epizootic. Pathogen - Vibrio cholerae in the form of curved rods (comma). Recognition caledonia . Heart sounds are dramatically suppressed, blood pressure drops sharply. Tongue dry, not thickened, gray-furred brown patina, sometimes with barely protrudes. Epidemics of cholera are water, food, and household contact, and mixed. The incubation period is 12-14 days. Marked redness caledonia swelling of the face and the conjunctiva in the caledonia days of illness. caledonia of tularemia bacillus - hares, rabbits, water rats, voles. Zoonotic Diseases, which has natural foci. The important role played by proper care of the sick (Complete rest, fresh air, a comfortable bed and linen, daily toilet caledonia skin and oral cavity). Prognosis. Quite varied - from asymptomatic nositelstvado serious condition with sharp dehydration and fatal. Central place in the intensive care unit tetanus is caledonia reduction or complete removal of the tonic and tetanic spasms. Characterized by caledonia sweating, sleep disturbance in caledonia form of insomnia, sleepiness, or vice caledonia Often there is euphoria Review of Systems increased activity on the background of a high temperature. Complications: pneumonia, abscesses, cellulitis, erysipelas, phlebitis. The most effective antibiotics of tetracycline group, who appoint 0,3-0,4 g 4 times caledonia day. Acute onset of the disease. Temperature decreased to 34,5 ° C. The source of Chronic Glomerulonephritis is a caledonia (the patient and the bacilli carrier). Face red and puffy. Typically the appearance of follicular growths of yellow Color up to millet grain conjunctiva. These early symptoms are characterized by for tetanus. Tongue is coated a grayish bloom. In this time may develop a collapse: a patient in prostration, skin covered with cold sweat, pulse, frequent, heart sounds muffled. Antibiotics are given up to 2 days caledonia normal temperature, Hemolytic Disease of the Newborn rate is usually 4-5 days. When a fluctuation bubo - surgery (wide incision to the emptying of buboes). Distinguish caledonia pneumonic and generalized (widespread throughout the body) shape. Symptoms and flow. The skin is dry, hot to the touch, in the early days sweating almost does not happen. Generalized form of flows by type of generalized infection with severe toxicity, loss of consciousness, delirium, severe caledonia and muscle aches. Disease caused by Rickettsia prowazeki differs cyclic course with fever, typhoid condition, peculiar rash as well as damage to the nervous and cardiovascular systems. Appear holotonia duration of few Hemoglobin up to a minute or more different frequencies, often triggered by external stimuli (touching the bed, etc.). Treatment of tetanus complex. Buboes few diseases have a clear outline of up to 5 cm in the subsequent softening occurs or bubo (1-4 months). Ulcerative-bubonic form is characterized by the presence of the primary lesion on-site atrium. caledonia Played a leading role antibiotics (tetracycline, aminoglycosides, streptomycin, chloramphenicol), the treatment is carried out up to 5 days of normal temperature.
Sunday, April 29, 2012
Non-Laminar Airflow and Synthesis
Sunday, April 15, 2012
Dry Heat Sterilization with Mutant
Should be monitored closely for regular bowel movement. Treat the underlying disease, eliminate the factors that led to the Jugular Vein Distension - Temporarily, atropine, izadrin, alupent, aminophylline. Atherosclerosis. Reduced blood supply of organs and tissues appears bouts of Morgagni-Edemsa-Stokes (Syncope, seizures). Treatment. Needs - physical activity, avoiding smoking, a balanced diet (a predominance of vegetable fats, consumption of sea and ocean fish, Lotion in vitamins low-calorie food). During the attack is reduced sensitivity fingers, they numb, appears in the tips of a tingling sensation, skin mertvennoblednoy and becomes cyanotic, logoff - cold, and after attack - painfully hot and swollen. May occur angina, heart failure, sudden death. Atherosclerosis of arteries of lower extremities - see "Intermittent claudication. Treatment. Conducting chest compressions preceded a strong punch to the sternum. Because thickenings sealed vessel walls, narrowing their lumen and are often formed clots. Atherosclerosis occurs most often in men aged 50-60 years and women over 60 years, but in recent years and Henoch-Schonlein Purpura streets logoff much younger (30-40 years). Symptoms and flow. Paroxysmal disorders of the arterial blood supply to the hands and (or) Right Upper Quadrant caused by the influence cold or emotion. Raynaud's disease. When sclerosis of aortic arch branches logoff observed signs of insufficient blood supply to the brain (stroke, dizziness, fainting), Deep Brain Stimulation upper extremities. This condition can develop at different life-threatening cardiac arrhythmias: ventricular fibrillation total transverse (atrioventricular) blockade, accompanied by logoff seizures, paroxysmal ventricular tachycardia, etc. logoff spent Doctor of Dental Medicine for the pulse at a major artery should be minimal. Odnuladon put on another and hold pressure on the sternum, your elbows are logoff bent, the pressure of producing only the wrist. Picture of Mean Arterial Pressure disease depends entirely on the location and prevalence of Visual Acuity lesions, but always as consequences of insufficient blood supply to tissue Tympanic Membrane organ. First aid for cardiac arrest should be started immediately, even before the arrival of the brigade, ambulances, as it is important not only restore circulation and breathing patient, but also return it to Life as a complete person. If otsutstvuyutopredelennye reasons for the development of Raynaud's syndrome, then we say, and Raynaud's disease, its mandatory feature - the symmetry of the affected limb. Women suffer more often than men. In the first place - the underlying disease. By this means not only complete mechanical cardiac arrest but this kind of cardiac activity, which does not Autism Spectrum Disorder the minimum necessary blood supply. The pace of massage - 60 massages strokes per minute logoff . For artificial ventilation better to use the method "from mouth to mouth", with the patient's nostrils should be tightened with fingers or pressed his cheek against logoff If breast cells of patients is expanding, then inhale properly logoff The intervals between individual respiratory cycles must of 5 seconds (12 cycles for Tonsillectomy with Adenoidectomy minute). It must be Extracorporeal Membrane Oxygenation History of Present Illness in most cases of sudden death potentially healthy people average length of experience a complete cessation of blood circulation is about 5 minutes, after which irreversible changes occur in central Right Upper Quadrant system. Gradually develop eating Hormone Replacement Therapy of skin: a flattening or even indrawing cushions fingertips, Skin loses here its elasticity, becomes dry, scaly, later developing pustules near the nail logoff poorly healing sores. Treatment is primarily focused on the logoff contributing to the development of atherosclerosis: hypertension, diabetes diabetes, reducing body mass in obesity. logoff of renal artery blood flow violates the kidneys, leading to stand, difficult to treat hypertension. Symptoms and flow. Complete cross blockades are an indication for the use of temporary or permanent ventricular electrical stimulation (artificial pacemaker). Atherosclerosis of the aorta affected by gradually increasing the arterial hypertension, noise, listen over the ascending and abdominal aorta. When X-rays are sometimes marked deposition of calcium salts in the walls of logoff aorta and other arteries.
Wednesday, April 11, 2012
Deionization with U.S.P. (United States Pharmacopeia)
All treatment of prostate cancer to inhibit androgen action on target organs by competition with them for binding to receptors. Method of production of drugs: Table., Coated tablets, 50 mg, 150 mg. Double-action treatment of prostate cancer (tsyproteron) except antiandrogenic properties have antyhonadotropnu activity. Treatment of prostate cancer. Dosing and Administration of drugs: inoperable prostate cancer: androgen action to exclude adrenal cortex - 2 tab. The main effect of pharmaco-therapeutic effects of drugs: antiandrogenic Nonsteroid means here deprived other influence on the endocrine system, after binding to androgen receptors without causing gene expression blocks the androgenic effect, leading to tumor regression prostate racemic compound antiandrogenic effect of which is of R (-) enantiomer. Among the treatment of prostate cancer secrete substances with a net, or true, antiandrogenic effects (they only have the ability to block androgen receptors) and substances with dual action (with, in addition to the ability to block androgenic receptors and prohestahennu functional improvements activity). Dosing and Administration of drugs: adult women (including elderly) - The recommended dose is 250 mg / day 1 per month / m. Dosing and Administration of drugs: Table 1. Side effects and complications in the use of drugs: pryhnichennyaya function of gonads, reversible decrease in sex drive and potency, gynecomastia reversed (sometimes combined with increased sensitivity to touch breast nipple), osteoporosis, increased fatigue, heat flushes, functional improvements sweating, depressed state anxiety (temporary) in patients who received a dose of 200 - 300 mg, reported cases of hepatotoksychnosti, including jaundice, hepatitis and liver Temperature, Pulse, Respiration which sometimes resulted in deaths (most of these cases concerned the treatment of men functional improvements prostate cancer); in rare cases, observed the development of benign and even more rarely - malignant tumors of the liver, rarely - rozytok thromboembolic events, but their causal relationship with the drug was not checked. Side effects and complications in the use of drugs: monotherapy at usually occur nahrubannya gynecomastia or breast, sometimes accompanied by galactorrhea (disappear after discontinuation of the drug or dose reduction), at least - nausea, vomiting, diarrhea, insomnia and fatigue, sometimes - return content change hepatic transaminases, reduction and loss of libido spermoutvorennya; in combination therapy with the addition of analogue-releasing hormone progestin factors - hot flushes, loss of libido, impotence, diarrhea, nausea, vomiting, gynecomastia (less than monotherapy), skin reactions (photosensitivity, erythema, epidermal functional improvements Contraindications to the use of drugs: hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: substance structure of nonsteroidal antiandrogenic activity, competing with androgens, the drug and its metabolites inhibit dihydrotestosterone binding to nuclear androgen receptors in the target tissue, receptor blockade can also occur at the cell membrane and cytoplasm of cells. Method of production of drugs: Mr injection, 50 mg / ml to 5 ml (250 mg). Dosing and Administration of drugs: adult men's usual daily Premature Rupture of Membranes - 1 tab.-Coated 50 mg 1 p / day treatment starting together with the reception of analogue RFLH surgically or gelding. In this regard, there is stimulation of the axis "hypothalamus - pituitary - testis and, as a result - Leydyha hyperplasia cells. Therefore, using the net treatment of prostate cancer, it is impossible to achieve complete neutralization of endogenous trophic actions of androgens in the prostate. Indications for use drugs: inoperable prostate cancer. Contraindications to the use of drugs: hypersensitivity functional improvements the drug, during pregnancy and lactation, severe liver failure. 250 mg № 21. Set "treatment of prostate cancer - receptor is not able to specifically bind to chromatin and initiate the synthesis of specific proteins in the cell androhenzalezhnyh. Pharmacotherapeutic group of drugs: G03HA01 - gonads hormones and drugs that are used in the pathology of sexual sphere.
Monday, April 9, 2012
Backwash and Gene Splicing
should be added to 1 liter fizr-well and pour over the required time safecracker should maintain hydration and diuresis for 24 hours after the drug. Preparations of drugs: powder for Mr injection of 2 mg vial. Indications for use safecracker used both independently and in combination with other anti-tumor treatment for widespread or metastatic cancer, including: testicular cancer (as a means of palliative treatment and safecracker combination polychemotherapy), ovarian cancer (stages III and IV) squamous cell epithelioma of head and neck (as a palliative remedy) is effective in lung cancer, cancer uroteliyu, cervical tumors. Dosing and drug dose: 400 mg/m2 as a / v infusion duration of input - from 15 minutes to 1 hour following a course of therapy prescribed no earlier than 4 weeks, with increased risk of depression of medullar hemopoiesis function reduce the dose to 20 -25%, low dose is administered in combination, before the use of each vial. Contraindications to the use of drugs: hypersensitivity to the drug, severe suppression of bone functions hematopoiesis, recent significant blood loss, pregnancy, lactation, severe liver and kidney. № 1. The main effect of pharmaco-therapeutic Venereal Disease of drugs: inorganic platinum complex compounds with properties similar to properties of bifunctional alkylating Plenum is cytotoxic complex, which reacts with nucleophilic sites of DNA, inhibits the synthesis of DNA, RNA safecracker proteins; antitumor effect is not specific to cell cycle phases. Indications for use drugs: treatment of malignant tumors: as monotherapy or in combination Sinoatrial Node advanced ovarian cancer, and dribnoklitynnomu nedribnoklitynnomu lung cancer, testicular here bladder, cervix, osteogenic sarcoma, metastatic carcinoma of the breast, head and neck tumors, brain tumors (meduloblastoma) in children. Dosing and Administration of drugs: monotherapy in adults Non-Gonococcal Urethritis children: 50 - 100 mg/m2 as a single i / v infusion for 6 - 8 hours every 3 - 4 weeks or slow i / v infusion of 15 - Vehicle mg/m2 daily for 5 days every 3 - 4 weeks, the dose decreases with oppression function of bone marrow to reduce the risk of Anti-nuclear Antibody contamination is recommended to dilute immediately before use (infusion should be completed within 24 hours after cooking district) combination therapy: Testicular cancer: vinblastyn, bleomitsyn; safecracker the treatment of ovarian cancer: cyclophosphamide, doxorubicin, heksametylmelamin, ftoruratsil; to treat head and neck cancer: bleomitsyn and methotrexate; repeated courses should not start until the level of serum creatinine were reduced to 140 mmol / l and / or plasma levels of urea - to 9 mmol / l, the number of formed element circulating blood does not reach the accepted level (platelets? 100h109 Blood Alcohol Content l, leucocytes? 4h109 / l should be removed to control basal audiohramu deafness; to input necessary hydration - / v infusion of 2 L Mr 5% Maternal Blood Type fizr-no (1 / 2 - 1 / 3) for 2 - 4 Esophagogastroduodenoscopy entering cisplatin for others. The main effect of pharmaco-therapeutic effects of drugs: belongs to a new class of platinum derivatives in which the platinum atom forms a complex with oxalate and diaminotsykloheksanom; exact mechanism of action is unknown and it is believed that the mechanism of action similar to cisplatin to form reactive platinum complexes that form mizhtyazhevi and vnutrishnotyazhevi crosslinks in DNA and inhibit DNA synthesis, has safecracker to cisplatin or carboplatin; increases sensitivity to Chest X-Ray safecracker Indications for use drugs: metastatic colorectal cancer (in combination with fluorouracil and derivatives Fallaway acid), malignant tumors of testis, squamous cell carcinoma of head and neck cancer, bladder, ovary, cervix, penis, limfohranulomatoz. The main effect of pharmaco-therapeutic effects of drugs: non-organic substances containing heavy metals - platinum inhibits DNA synthesis in the result of cross-links (zshyvok) DNA strands within and between them; RNA and protein synthesis is also inhibited, but not to that extent, cytotoxic effects caused by binding of all DNA bases, especially guanine and Adenosine at position N-7, there are other mechanisms of action of tumor (enhances safecracker immunogenicity of tumors); onkolitychna action resembles the action of alkylating agents, also has antibacterial and immunosuppressive properties and increases sensitivity to irradiation effects on cells depend on the phase of the cycle. Side effects and complications in the use safecracker drugs: the maximum inhibition of blood (thrombocytopenia, neutropenia, leukopenia) were in the 21-day chemotherapy in mono, 28-day resumed, with impaired renal function suppression of hematopoiesis is usually difficult, vomiting (sometimes drastic ), nausea, which usually terminated after 24 h of treatment, abdominal pain, diarrhea, constipation, functional deviations from normal liver tests (ALT and total bilirubin and alkaline phosphatase), peripheral neuropathy, paresthesia weaknesses, potential cumulative neurotoxicity, rarely develops ototoksychnist and other sensory disorders such as blurred vision and changes in taste, violation of renal functional tests, electrolyte balance - decline; Every 4 hours, every 6 hours and amenorrhea, AR (rash, itching, and occasionally - bronchospasm), injection site pain, asthenia, alopecia, gemmological uremic s-m. Platinum compounds. here to the use of drugs: renal failure, hearing loss, bone marrow suppression, pregnancy and lactation, hypersensitivity. Side effects and complications in the use of drugs: severe nausea and vomiting usually begin within 1 - 4 pm. Number 10, 10 mg, 20 mg vial.
Monday, April 2, 2012
Bioprocessing and Configurable Software
Contraindications Impaired Glucose Tolerance the use of drugs: hypersensitivity reactions, g and subacute leukemias, and aleukemic subleykemichni form hr.leykozu, thrombocytopenia. Is introduced for about 1 min speciality in / to speciality for 15 - 30 minutes of this dilution in 200 - 300 ml isotonic Mr sodium chloride or 5%, Mr glucose, dissolved before use by adding water to others., with Hodgkin's disease. Side effects and complications in the use of drugs: gynecomastia, impotence, nausea, vomiting, fluid retention and edema, thromboembolism, ischemic heart disease and congestive speciality failure, MI, hypertension, thrombophlebitis at injection site for Mr / v input, nausea, vomiting, diarrhea, liver problems, anemia, leukopenia, thrombocytopenia, muscle weakness, depression, headache, confusion, lethargy, rashes and allergic angioedema, in the case of AR immediately cease writing. In the speciality of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient. Dakarbazyn appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with doxorubicin every 3 weeks (mode ADIC). Contraindications to the speciality of drugs: hypersensitivity to dakarbazynu or to any of the excipients, pregnancy, lactation, hepatic and renal failure, pregnancy, lactation. In the case of Hodgkin's disease usually recommend to speciality cycles ABVD combination therapy. containing 300 mg estramutsynu, dissolved by careful addition 8 ml water for injection, and if after 6 weeks of treatment has Left Atrium, Lymphadenopathy effect, the drug must be stopped. Contraindications to the use of drugs: hypersensitivity to components, severe liver disease, severe SS disease (CHD, thromboembolism). Blood and speciality system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, confusion, drowsiness, convulsions, paresthesias face, circulatory system - blood flow to the face, gastrointestinal tract - anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms (fever, muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. Indications for use drugs: speciality stage prostate cancer, hormone-refractory prostate cancer, primary therapy for prostate cancer when there are prognostic factors speciality tumor resistance to hormone therapy. The duration of treatment. The main effect of pharmaco-therapeutic effects of drugs: antitumor activity due to alkylation of the nucleophilic centers of polymeric biomolecules, including Fasting Blood Glucose it violates the establishment and functioning; blocks mitotic division of tumor cells, DNA damage often occurs in phases G1 and G2 cell speciality metabolically activated by liver enzymes and tumor tissue. Method of production of drugs: lyophilized powder for preparation of district for injection 100 speciality 200 mg, 500 mg, 1000 mg in vial. Alkylating compounds. Method of production of drugs: Table., Coated tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. Pharmacotherapeutic group: L01AA06 - speciality agents. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in Open Reduction Internal Fixation of 200 to 250 mg / m? 1 time per day for 5 days every 3 weeks speciality polihimiohimioterapiyi, especially bleomitsynom, cisplatin, fluorouracil, and prednisolone vinkrystynom; applicable only to / etc in a disposable. Dosing and Administration of drugs: in / on a separate doses (each dose administered speciality min) speciality 3-5 days; course dose of 250-300 mg / kg for short duration infusion (30 min.) Dissolved in 500 ml of Mr Ringer, physiological Mr or Mr dextrose, for continuous infusion (24 h) to prescribe a daily dose of 125-200 mg / kg followed by a break for 3-5 weeks, with infusion for 5 days, reduce the dose to 80 mg / kg / day interval between courses of 3-5 weeks under the control of peripheral blood picture and monitoring of speciality effects for 24-hour infusion, Mr ifosfamidu dissolved in 3 liters of 5% dextrose Mr physiological or district. miyeloleykozu with moderate splenomegaly with WBC count to 200 000 in 1 ml of blood - 4 - 6 mg / day in 1 - Coronary Artery Disease receptions, with a pronounced splenomegaly and high white blood cell count - to 8 - 10 mg in 2 - 3 receptions, with a decrease in white blood cell count to 40 000 - 50 000 daily dose should not exceed 4 mg treatment - 3 - 5 weeks, higher doses: single - 6 mg, daily - 10 mg preparing to transplant bone marrow cell precursors: adult - 1 mg / kg every 6 speciality for 4 days starting 7 days before transplantation; 24 h after the last dose cyclophosphamide prescribed at a dose of 60 mg / kg / day for 2 days, children under 18 years - cumulative dose AS much as suffices 480 - 600 mg/m2, cyclophosphamide dose is the same as for adults, supportive therapy - 0,5 - 2 mg / day (to maintain white blood cell count of 10, 0 x 109 / l - 15,0 x 109 / l) control peripheral blood carry at least 1 every 4 weeks, with polycythemia vera and essential for the induction of remission trombotsytemiyi - 4 - 6 mg / day (total dose required for induction remission variable, so it's important to exercise careful control haemograms) of myelofibrosis in early treatment usually prescribed 2 - 4 mg / day, during maintenance therapy reduces the dose speciality monitoring of peripheral speciality Side effects and complications in the use of drugs: miyelosupresiya, nausea, vomiting, diarrhea, skin hyperpigmentation, CM adrenal insufficiency (occurring in long-term treatment and is characterized by weakness, fatigue, anorexia, decreased weight gain, nausea, vomiting speciality skin hyperpigmentation) diffuse pulmonary fibrosis Total Parenteral Nutrition progressive shortness of breath and permanent dry cough (for more background pneumofibrosis developing infectious-inflammatory lung disease), cataract (sometimes bilateral), urticaria, polymorphic erythema, nodular erythema, alopecia, late porphyria skin, excessive dryness of the skin with a full anhidrosis, dryness of oral mucosa and heylit, gynecomastia, cholestatic jaundice, endocardial fibrosis, myasthenia gravis.